Correlation Between Li Kang and SynCore Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Li Kang and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Li Kang and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Li Kang Biomedical and SynCore Biotechnology Co, you can compare the effects of market volatilities on Li Kang and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Li Kang with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Li Kang and SynCore Biotechnology.

Diversification Opportunities for Li Kang and SynCore Biotechnology

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between 6242 and SynCore is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Li Kang Biomedical and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and Li Kang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Li Kang Biomedical are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of Li Kang i.e., Li Kang and SynCore Biotechnology go up and down completely randomly.

Pair Corralation between Li Kang and SynCore Biotechnology

Assuming the 90 days trading horizon Li Kang Biomedical is expected to under-perform the SynCore Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Li Kang Biomedical is 8.71 times less risky than SynCore Biotechnology. The stock trades about -0.02 of its potential returns per unit of risk. The SynCore Biotechnology Co is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  3,395  in SynCore Biotechnology Co on November 5, 2024 and sell it today you would earn a total of  90.00  from holding SynCore Biotechnology Co or generate 2.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Li Kang Biomedical  vs.  SynCore Biotechnology Co

 Performance 
       Timeline  
Li Kang Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Li Kang Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Li Kang is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SynCore Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Li Kang and SynCore Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Li Kang and SynCore Biotechnology

The main advantage of trading using opposite Li Kang and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Li Kang position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.
The idea behind Li Kang Biomedical and SynCore Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities